Evonik has released a new strategy to better balance its portfolio and accelerate growth. Under new leadership, the company is aiming to become ‘best in class’ in the specialty chemicals field.
“I am excited at the opportunities that lie ahead for Evonik,” said Chief Executive Officer, Christian Kullmann. “We will enhance value creation for our stakeholders by sharpening our focus on specialty chemicals, driving innovation and encouraging a trustful corporate culture of measured risk taking.”
Evonik is aiming to grow sales volumes faster than global GDP and lift its EBITDA margin into a sustainably higher range of 18 to 20 percent, up from 16 to 18 percent.
“We want to focus more strongly on businesses with a clear specialty chemicals character,” added Kullmann. “Going forward, our portfolio will have a higher share of growth businesses.”